ATE223915T1 - Neue heterozyklische chemie - Google Patents

Neue heterozyklische chemie

Info

Publication number
ATE223915T1
ATE223915T1 AT96913474T AT96913474T ATE223915T1 AT E223915 T1 ATE223915 T1 AT E223915T1 AT 96913474 T AT96913474 T AT 96913474T AT 96913474 T AT96913474 T AT 96913474T AT E223915 T1 ATE223915 T1 AT E223915T1
Authority
AT
Austria
Prior art keywords
pct
sec
heterocyclic chemistry
date
new heterocyclic
Prior art date
Application number
AT96913474T
Other languages
English (en)
Inventor
Jane Marie Lundbeck
Birgitte Sokilde
Per Olaf Sorensen
Original Assignee
British Tech Group Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group Int filed Critical British Tech Group Int
Application granted granted Critical
Publication of ATE223915T1 publication Critical patent/ATE223915T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT96913474T 1995-05-05 1996-05-01 Neue heterozyklische chemie ATE223915T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK52095 1995-05-05
PCT/DK1996/000198 WO1996034865A1 (en) 1995-05-05 1996-05-01 Novel heterocyclic chemistry

Publications (1)

Publication Number Publication Date
ATE223915T1 true ATE223915T1 (de) 2002-09-15

Family

ID=8094479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96913474T ATE223915T1 (de) 1995-05-05 1996-05-01 Neue heterozyklische chemie

Country Status (10)

Country Link
US (1) US5834482A (de)
EP (1) EP0823909B1 (de)
JP (1) JPH11505217A (de)
AT (1) ATE223915T1 (de)
AU (1) AU5644296A (de)
DE (1) DE69623610T2 (de)
DK (1) DK0823909T3 (de)
ES (1) ES2182975T3 (de)
PT (1) PT823909E (de)
WO (1) WO1996034865A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0823905A1 (de) * 1995-05-05 1998-02-18 Novo Nordisk A/S Neue heterocyclische chemie
US7101878B1 (en) 1998-08-20 2006-09-05 Agouron Pharmaceuticals, Inc. Non-peptide GNRH agents, methods and intermediates for their preparation
ATE288268T1 (de) 1998-12-10 2005-02-15 Agouron Pharma Nichtpeptidische antagonisten des glp-1 rezeptors und verwendungsmethoden
GB9925880D0 (en) * 1999-11-01 1999-12-29 British Tech Group Int B-Carboline derivatives
US20040010033A1 (en) * 2001-02-20 2004-01-15 Pfizer Inc. Non-peptide GnRH agents, methods and intermediates for their preparation
WO2009120717A2 (en) 2008-03-24 2009-10-01 Medivation Technologies, Inc. Pyrido [3, 4-b] indoles and methods of use
CN102711467A (zh) * 2009-09-23 2012-10-03 梅迪维新技术公司 吡啶并[3,4-b]吲哚类及使用方法
US9079904B2 (en) 2009-09-23 2015-07-14 Medivation Technologies, Inc. Pyrido[3,4-B]indoles and methods of use
FR2953838B1 (fr) * 2009-12-10 2012-02-24 Sanofi Aventis Derives de 9h-beta-carboline (ou 9h-pyridino[3,4-b]indole) trisubstitues, leur preparation et leur utilisation therapeutique
FR2953837B1 (fr) * 2009-12-10 2012-03-09 Sanofi Aventis Derives 9h-pyridino[3,4-b]indole disubstitues, leur preparation et leur utilisation therapeutique
US8791132B2 (en) 2011-02-18 2014-07-29 Medivation Technologies, Inc. Compounds and methods for treatment of hypertension

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539407A (en) * 1983-12-13 1985-09-03 American Home Products Corporation β-Carboline anticonvulsants

Also Published As

Publication number Publication date
DK0823909T3 (da) 2003-01-20
US5834482A (en) 1998-11-10
WO1996034865A1 (en) 1996-11-07
DE69623610T2 (de) 2003-02-20
ES2182975T3 (es) 2003-03-16
PT823909E (pt) 2002-12-31
DE69623610D1 (de) 2002-10-17
AU5644296A (en) 1996-11-21
JPH11505217A (ja) 1999-05-18
EP0823909B1 (de) 2002-09-11
EP0823909A1 (de) 1998-02-18

Similar Documents

Publication Publication Date Title
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
TW345575B (en) Pharmaceutical composition comprising an inhibitor for ras farnesylation and the preparation of the inhibitor compound
DE69616749D1 (de) Arylsubstituierte 5,5 verknüpfte aromatische nitroverbindungen als entzündungshemmende wirkstoffe
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
ZA959451B (en) 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
DE60236456D1 (de) Liposomale abgabe von verbindungen auf vitamin-e-basis
DE69623610D1 (de) Neue heterozyklische chemie
PL316563A1 (en) Application of derivatives of carboxylic acids as therapeutic agents
DE69533194D1 (de) PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN
NO943280D0 (no) Fremgangsmåte for fremstilling av ger derav
UY25807A1 (es) Caprolactamas sustituidas, composiciones farmacéuticas que las contienen, y su uso en el tratamiento de tumores.
PL317349A1 (en) Organic compounds
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
NO933241L (no) Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
MA26734A1 (fr) Derives de 1-trifluoromethyl -4-hydroxy- 7-piperidinyl- aminomethylchromane, procede pour leur preparation et compositions pharmaceutiques les contenant
DE69619868D1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
PT99280A (pt) Processo de preparacao de derivados do indolo e de composicoes farmaceuticas
DE59504643D1 (de) Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
ES2164665T3 (es) Inhibidores de proteasas retrovirales.
DE59504077D1 (de) Neue 2.4-diphosphonoglutarsäurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
GR3035010T3 (en) New derivatives of glycylanilides, preparation and therapeutical application

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee